Compass Therapeutics, Inc. (CMPX) › Operating Cash FlowCompass Therapeutics, Inc. (CMPX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$31.74M2020: -$26.80M2021: -$19.67M2022: -$34.12M2023: -$40.62M2024: -$44.85M2025: -$49.14M-$49.14M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$49.14M-9.6%2024-$44.85M-10.4%2023-$40.62M-19.0%2022-$34.12M-73.5%2021-$19.67M+26.6%2020-$26.80M+15.6%2019-$31.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share